Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
出版年份 2020 全文链接
标题
Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
作者
关键词
-
出版物
NATURE MEDICINE
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-03-03
DOI
10.1038/s41591-020-0755-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease
- (2019) Rik Ossenkoppele et al. NEUROLOGY
- Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes
- (2019) Matthew P. Pase et al. JAMA Neurology
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
- (2019) Niklas Mattsson et al. JAMA Neurology
- Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status
- (2019) Sebastian Palmqvist et al. JAMA Neurology
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer’s Disease
- (2018) Che-Chuan Yang et al. JOURNAL OF ALZHEIMERS DISEASE
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Comparing18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease
- (2018) Niklas Mattsson et al. NEUROLOGY
- Tau Kinetics in Neurons and the Human Central Nervous System
- (2018) Chihiro Sato et al. NEURON
- Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms
- (2018) Sebastian Palmqvist et al. Alzheimers & Dementia
- Biomarkers for tau pathology
- (2018) Michael Schöll et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology
- (2018) Ruben Smith et al. JAMA Neurology
- Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome
- (2017) Harutsugu Tatebe et al. Molecular Neurodegeneration
- Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
- (2017) Günter U. Höglinger et al. MOVEMENT DISORDERS
- Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
- (2017) Anne Maass et al. NEUROIMAGE
- Blood-based NfL
- (2017) Oskar Hansson et al. NEUROLOGY
- Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
- (2017) Sebastian Palmqvist et al. Nature Communications
- In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum
- (2016) Hanna Cho et al. ANNALS OF NEUROLOGY
- 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology inMAPTmutation carriers
- (2016) Ruben Smith et al. BRAIN
- Modeling Strategies for Quantification of In Vivo 18 F-AV-1451 Binding in Patients with Tau Pathology
- (2016) Andreas Hahn et al. JOURNAL OF NUCLEAR MEDICINE
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Plasma tau in Alzheimer disease
- (2016) Niklas Mattsson et al. NEUROLOGY
- Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis
- (2016) Niklas Mattsson et al. Nature Communications
- Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study
- (2015) Vincent Chouraki et al. Alzheimers & Dementia
- Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42
- (2014) Sebastian Palmqvist et al. JAMA Neurology
- Criteria for the diagnosis of corticobasal degeneration
- (2013) M. J. Armstrong et al. NEUROLOGY
- Plasma tau levels in Alzheimer's disease
- (2013) Henrik Zetterberg et al. Alzheimers Research & Therapy
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010
- (2012) Thomas G. Beach et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: Results of a pilot study
- (2012) Jeffrey Randall et al. RESUSCITATION
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations
- (2010) David M Rissin et al. NATURE BIOTECHNOLOGY
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started